When should a newborn who has just completed universal hearing screening have a follow‑up audiologic evaluation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Follow-Up Audiogram After Newborn Hearing Screening

Infants who fail the initial newborn hearing screening should receive repeat testing between 2 and 8 weeks after hospital discharge, with comprehensive diagnostic audiological evaluation—including frequency-specific ABR—completed by 3 months of age. 1, 2

Timeline for Follow-Up: The 1-3-6 Rule

The American Academy of Pediatrics establishes clear benchmarks for the entire screening-to-intervention pathway 1, 3:

  • Screening: Complete by 1 month of age 1, 3
  • Diagnostic evaluation: Complete by 3 months of age for all infants who fail screening 1, 3, 2
  • Intervention: Hearing aids fitted and early intervention services initiated by 6 months of age 1, 3

Immediate Post-Discharge Protocol

For Infants Who Fail In-Hospital Screening

  • Schedule outpatient rescreening between 2 and 8 weeks after discharge 1, 2
  • If the infant fails the second screening, refer immediately for comprehensive audiological evaluation that must be completed no later than 3 months of age 1, 2

For NICU Infants Who Fail ABR Screening

  • Do not send for routine outpatient rescreening 1, 3
  • Refer directly to a pediatric audiologist for diagnostic evaluation, as NICU infants have 10-20 fold increased risk of neural hearing loss 1, 3

Comprehensive Diagnostic Evaluation (Birth to 6 Months)

When permanent hearing loss is suspected, the diagnostic battery must include 1, 2:

  • Frequency-specific ABR using air-conducted tone bursts to determine degree and configuration of hearing loss in each ear 1, 2
  • Click-evoked ABR with both condensation and rarefaction stimuli to detect cochlear microphonic and assess for auditory neuropathy 1, 2
  • Otoacoustic emissions (distortion product or transient evoked) to assess cochlear outer hair cell function 1, 2
  • Tympanometry using 1000-Hz probe tone (infant-appropriate) 1, 2
  • Child and family history with risk factor evaluation 1, 2
  • Parental report of infant's auditory responses 1

Understanding False-Positive Results

Parents require clear counseling about screening accuracy 1, 2:

  • In low-risk populations, only 2% of infants who fail OAE screening actually have sensorineural hearing loss 1, 3
  • Overall, approximately 6.7% of infants who fail in-hospital screening are eventually diagnosed with bilateral hearing loss 1, 3
  • There are 25 to 50 false positives for each true case of hearing impairment in low-risk populations 1

Critical Pitfalls to Avoid

Do Not Assume a Passed ABR Means No Hearing Loss

  • Approximately 23% of infants with permanent hearing loss at 9 months will have passed automated ABR screening after failing OAE 4
  • Most automated ABR equipment is designed to detect moderate or greater hearing loss and will miss mild losses 4
  • 77% of missed cases have mild hearing loss (≤40 dB hearing level) 4
  • Recent evidence shows that 28% of infants who fail TEOAE but pass AABR have hearing impairment confirmed at 1-year follow-up 5

Do Not Delay Beyond 3 Months

  • Visual reinforcement audiometry cannot be performed reliably before 8-9 months of age, making early ABR testing essential 1
  • Diagnostic ABR can be performed as early as 3 months and should not be delayed 1, 2
  • Early intervention before 6 months is critical for language development outcomes 1, 3

Do Not Ignore Loss to Follow-Up Risk

  • 13% to 31% of infants who fail initial screening do not return for follow-up testing 1, 3
  • Hospitals should implement systematic protocols including scheduled appointments before discharge, written instructions, and phone call reminders 6
  • Nurse practitioner-led education interventions at bedside before discharge significantly improve follow-up rates 6

Special Populations Requiring Enhanced Surveillance

Even infants who pass newborn screening require ongoing surveillance if they have risk factors 1, 3:

  • NICU admission ≥2 days 1, 3
  • Family history of childhood sensorineural hearing loss 1, 3
  • Congenital infections (TORCH agents) 1, 3
  • Craniofacial abnormalities 1, 3
  • Syndromes associated with hearing loss 1, 3
  • Hyperbilirubinemia requiring exchange transfusion 1, 3
  • Culture-positive sepsis 1, 3

These infants require at least one diagnostic audiology assessment by 24-30 months of age regardless of newborn screening results 1, 3

Timing Considerations for Optimal Screening

  • Do not screen before 24 hours of life unless medically necessary, as false-positive rates are significantly higher due to middle-ear fluid, vernix, and cerumen 3
  • Screening after the first 24 hours reduces false-positive results 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Newborn Hearing Screening and Follow-up

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Universal Newborn Hearing Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Neonatal hearing screening - does failure in TEOAE screening matter when the AABR test is passed?

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2024

Research

Follow-up after a failed newborn hearing screen: a quality improvement study.

ORL-head and neck nursing : official journal of the Society of Otorhinolaryngology and Head-Neck Nurses, 2012

Related Questions

When should a 4-month-old infant with an ear tag and normal initial Otoacoustic Emission (OAE) test results undergo a Brainstem Evoked Response Audiometry (BERA) test?
What is the next step for infants who fail the Otoacoustic Emissions (OAE) screening, specifically regarding the Automated Auditory Brainstem Response (ABR) test?
Where should an infant with congenital left‑ear hearing loss be referred?
What is the best method to evaluate hearing in a 2-month-old infant?
What is the recommended hearing test for a 9-month-old infant?
How do I identify dilated cardiomyopathy in an adult presenting acutely with heart failure or cardiogenic shock?
How should I evaluate a patient in the emergency department who presents with an acute change in mental status suggestive of delirium?
In elderly patients or those on antihypertensive or diuretic therapy, with Parkinson’s disease, autonomic neuropathy, recent syncope, or after medication changes affecting vascular tone, how often should orthostatic blood pressures be checked?
What is the albumin‑creatinine ratio (ACR), what are the normal and abnormal values, and how should an elevated ACR be confirmed and managed in patients at risk for chronic kidney disease?
Is it appropriate for a primary‑care physician to refer a patient with a diagnosed benign enchondroma of the femur to orthopedics?
What are the first‑line pharmacologic treatments for an adult with alcohol use disorder, and how should I choose between oral naltrexone, oral acamprosate, and disulfiram based on hepatic function, renal function, treatment goals (abstinence vs reduction), and likelihood of adherence?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.